Overexpression of MicroRNA-16 Alleviates Atherosclerosis by Inhibition of Inflammatory Pathways

Figure 1

Expression and roles of miR-16 in coronary artery disease (CAD) patients and association of miR-16 expression and the severity of CAD evaluated by Gensini score. Relative miR-16 expression level in peripheral blood mononuclear cells (a) and plasma (b); ELISA detection of the protein levels of IL-6 (c) and IL-10 (d) in patients with chest pain symptoms but safely excluded by coronary angiogram () and from CAD patients who had at least one diseased vessel (). (e) IL-10/IL-6 ratio; the Spearman correlation analysis to indicate the association of miR-16 levels and IL-6 (f), IL-10 (g), or IL-10/IL-6 (h). The Spearman correlation analysis to indicate miR-16 expression level in peripheral blood mononuclear cells (i), plasma (j), and Gensini score. Data are represented as the ; , compared with control.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)